Showing results (331-340 of 346) with videos related to
Sort By:
Pageof 35
European Journal of Nuclear Medicine and Molecular Imaging|November 10, 2019
Management implications of fluorodeoxyglucose positron emission tomography/magnetic resonance in untreated intrahepatic cholangiocarcinomaCristina Ferrone, Lipika Goyal, Motaz Qadan, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinomaLiz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.Journal of Neurology, Neurosurgery, and Psychiatry|February 12, 2015
Short-interval observational data to inform clinical trial design in Huntington's diseaseNicola Z Hobbs, Ruth E Farmer, Elin M Rees, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 6, 2012
A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life resultsRiccardo Soffietti, Martin Kocher, Ufuk M Abacioglu, et al.BMC Nephrology|March 8, 2014
Burden and predictors of hypertension in India: results of SEEK (Screening and Early Evaluation of Kidney Disease) studyYoussef M K Farag, Bharati V Mittal, Sai Ram Keithi-Reddy, et al.Blood|September 2, 2008
Positron emission tomography has a high negative predictive value for progression or early relapse for patients with residual disease after first-line chemotherapy in advanced-stage Hodgkin lymphomaCarsten Kobe, Markus Dietlein, Jeremy Franklin, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 13, 2011
Eight cycles of escalated-dose BEACOPP compared with four cycles of escalated-dose BEACOPP followed by four cycles of baseline-dose BEACOPP with or without radiotherapy in patients with advanced-stage hodgkin's lymphoma: final analysis of the HD12 trial of the German Hodgkin Study GroupPeter Borchmann, Heinz Haverkamp, Volker Diehl, et al.BMC Nephrology|May 30, 2013
Epidemiology and risk factors of chronic kidney disease in India - results from the SEEK (Screening and Early Evaluation of Kidney Disease) studyAjay K Singh, Youssef M K Farag, Bharati V Mittal, et al.European Journal of Cancer (Oxford, England : 1990)|September 2, 2008
Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 'boost versus no boost'Sandra Collette, Laurence Collette, Tom Budiharto, et al.Transplantation and Cellular Therapy|May 7, 2025
Changes in Chronic Graft-versus-Host Disease Treatment Over Time: A 15-Years Survey Within Allogeneic Hematopoietic Stem Cell Transplant Centers in Germany, Austria, and SwitzerlandAlexander Denk, Matthias Alexander Fante, Silke Heidenreich, et al.Pageof 35